Henrik Rhenman

Henrik Rhenman founded Rhenman & Partners Asset Management in Stockholm, building one of the most consistently successful healthcare-focused hedge funds in Europe. The firm's flagship Rhenman Healthcare Equity L/S fund has generated exceptional long-term returns through systematic fundamental analysis of pharmaceutical, biotechnology, and medical device companies. Rhenman's approach combines scientific analysis of drug pipelines with financial valuation and portfolio construction discipline. The fund takes both long and short positions based on views about clinical trial outcomes, regulatory decisions, and relative valuation. Rhenman & Partners has become a leading name in Scandinavian alternative asset management, demonstrating that specialized sector expertise can generate significant alpha in healthcare, where informational advantages are available to genuinely expert analysts.